Q. I\u2019ve been taking a low-dose Jardiance pill for two years. The endocrinologist at the hospital put me on it after my heart attack and triple bypass. My blood sugar is under control, and I have experienced no noticeable side effects.<\/p>\n
I purchase the drug from a Canadian pharmacy. It costs me about $400\/year.<\/p>\n
A. If you were buying Jardiance (empagliflozin) without insurance in the U.S., the monthly price tag could run more than $600. Purchasing your medicine from a legitimate online Canadian pharmacy would bring the price down substantially.<\/p>\n
You can learn more about the pros and cons of using Jardiance to treat Type 2 diabetes in our \u201ceGuide to Preventing and Treating Diabetes.\u201d We also discuss how to safely purchase medications from Canada in our \u201ceGuide to Saving Money on Medicines.\u201d These online resources may be found under the Health eGuides tab at www.PeoplesPharmacy.com.<\/p>\n
Q. Guaifenesin is a miracle drug for me. For most of my life, I\u2019ve had sinus problems. Even with a big sinus infection, guaifenesin clears the congestion within a day or two. Nothing a doctor has prescribed has ever been better.<\/p>\n
A. Guaifenesin is sold over the counter as an expectorant. That means it is supposed to loosen mucus and ease congestion. We\u2019re glad you get such great relief from this very old drug. Researchers have recently raised questions about its effectiveness, though (Otolaryngology-Head and Neck Surgery, May 28, 2024). <\/p>\n
In their column, Joe and Teresa Graedon answer letters from readers. Write to them in care of King Features, 628 Virginia Drive, Orlando, FL 32803, or email them via their website: www.PeoplesPharmacy.com. Their newest book is \u201cTop Screwups Doctors Make and How to Avoid Them.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Q. I\u2019ve been taking a low-dose Jardiance pill for two years. The endocrinologist at the hospital put me…\n","protected":false},"author":3,"featured_media":259097,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[210,1060,67,132,68],"class_list":{"0":"post-460419","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115752995910778068","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/460419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=460419"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/460419\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/259097"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=460419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=460419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=460419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}